Literature DB >> 3884468

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).

R Jian, F Ducrot, C Piedeloup, J Y Mary, Y Najean, J J Bernier.   

Abstract

Symptoms suggesting gastroparesis in patients without gastric outlet obstruction are very common but their relation to an objective delay of gastric emptying has been poorly investigated. A dual isotopic technique was used to evaluate patients with non-obstructive dyspepsia (idiopathic and secondary) (part 1) and to assess the effects of a new gastrokinetic agent: cisapride, on gastric emptying in such patients (part 2). Sixty patients with postprandial dyspeptic symptoms (vomiting, nausea, gastric bloating or full feeling) and without lesions at upper endoscopy were studied. They were distributed into three groups: idiopathic dyspepsia (n = 31), postvagotomy dyspepsia (n = 16) and dyspepsia secondary to medical disorders (n = 13). All patients ingested the same ordinary meal; 99mTc sulphur colloid tagged egg white was the solid phase marker and 111In chloride was the liquid phase marker. In part 1, evaluation of gastric emptying in the first 50 patients shows a delay of gastric emptying rate of solids and liquids as compared with controls. Striking differences separate the three groups of patients, however, percentages of delayed gastric emptying rate of solids and or liquids averaged 90% in postvagotomy or secondary dyspepsia groups whereas it was 44% in idiopathic dyspepsia group. Moreover, liquid emptying rate was often the only one impaired in idiopathic dyspepsia, and in 12 of the 27 patients of this group the faster emptying rate of liquids as compared with that of solids (always found in normal subjects), could not be evidenced. In part 2, 10 patients entered a double blind cross over study of cisapride (8 mg intravenously). A significant increase of solid (p<0.01) and liquid (p<0.05) emptying rates was found in patients with initial gastric emptying delay. This study emphasises the importance of an objective evaluation of gastric emptying in the presence of symptoms of gastric stasis and suggests that specific local acting therapy may be useful in patients with identified abnormal gastric emptying.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884468      PMCID: PMC1432519          DOI: 10.1136/gut.26.4.352

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum).

Authors:  P KASSANDER
Journal:  Ann Intern Med       Date:  1958-04       Impact factor: 25.391

2.  Gastric emptying of solid meals in diabetics.

Authors:  J H Scarpello; D C Barber; R V Hague; D R Cullen; G E Sladen
Journal:  Br Med J       Date:  1976-09-18

3.  Gastric emptying in diabetic autonomic neuropathy.

Authors:  I W Campbell; R C Heading; P Tothill; T A Buist; D J Ewing; B F Clarke
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

4.  [The value of measuring the gastric emptying rate with the scinticamera (author's transl)].

Authors:  A Brassinne; D Linsmaux; G Merchie
Journal:  Acta Gastroenterol Belg       Date:  1978 Nov-Dec       Impact factor: 1.316

5.  Gastric emptying and antral motility in reflux esophagitis. Effect of oral metoclopramide.

Authors:  J Behar; G Ramsby
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

6.  Gastric emptying of solid food in normal man and after subtotal gastrectomy and truncal vagotomy with pyloroplasty.

Authors:  I L MacGregor; P Martin; J H Meyer
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

7.  Effect of metoclopramide in chronic gastric retention after gastric surgery.

Authors:  W H Metzger; R Cano; R A Sturdevant
Journal:  Gastroenterology       Date:  1976-07       Impact factor: 22.682

8.  Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol.

Authors:  J R Malagelada; W D Rees; L J Mazzotta; V L Go
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

9.  Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation.

Authors:  L Van de Mierop; L Rutgeerts; B Van den Langenbergh; A Staessen
Journal:  Digestion       Date:  1979       Impact factor: 3.216

10.  Gastric emptying of solid meals after truncal vagotomy and pyloroplasty in human subjects.

Authors:  D J Cowley; P Vernon; T Jones; H I Glass; A G Cox
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

View more
  51 in total

Review 1.  How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study.

Authors:  M Willems; A O Quartero; M E Numans
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Gastric emptying rate of solids in patients with nonulcer dyspepsia.

Authors:  B D Maes; Y F Ghoos; M I Hiele; P J Rutgeerts
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Gastric emptying of two radiolabelled antacids.

Authors:  J Monés; I Carrió; M Roca; M Estorch; R Calabuig; S Sainz; C Martinez-Duncker; F Vilardell
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

4.  Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.

Authors:  P Greally; F J Hampton; U M MacFadyen; H Simpson
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 5.  Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature.

Authors:  Emma M Tillman; Keaton S Smetana; Likeselam Bantu; Merrion G Buckley
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

6.  Effect of cisapride on gastric emptying in dyspeptic patients.

Authors:  J L Urbain; J A Siegel; N C Debie; S P Pauwels
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

7.  Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.

Authors:  R J Fraser; M Horowitz; A F Maddox; J Dent
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 8.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

9.  Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.

Authors:  D D Kerrigan; M E Taylor; N W Read; A G Johnson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

10.  Cisapride for gastro-oesophageal reflux and peptic oesophagitis.

Authors:  S Cucchiara; A Staiano; C Capozzi; C Di Lorenzo; A Boccieri; S Auricchio
Journal:  Arch Dis Child       Date:  1987-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.